IPVS Educational Webinar Series 2021 – The Future of HPV Research
IPVS is pleased to announce the following session of our Educational Webinar Series for 2021 Session II: The Future of HPV Research: Capitalizing on Current Opportunities 22 April 2021 17:00-18:00 CET (Geneva)/ 08:00-09:00 PST (Los Angeles) Moderator: Dr. Elisabeth McClymont, PhD, University of Montreal, Department of Obstetrics & Gynecology Topic: The aim of this session […]
IPVS webinar: Prevention of anal cancer
IPVS webinar Prevention of anal cancer: Will the ANCHOR study be sufficient to start screening programs? Tuesday, 9th August 2022 17:00-18:30 CEST (Geneva) / 11:00-12:30 EDT (New York) Topic: Join international experts in a discussion around prevention of anal cancer. In this session, the speakers will discuss the burden of anal cancer, the clinical findings […]
IPVS webinar – HPV-Related Head and Neck Cancers: Epidemiology, novel therapeutics and impact
IPVS webinar – HPV-Related Head and Neck Cancers: Epidemiology, novel therapeutics and impact Thursday, July 27, 2023 16:00 – 17:00 CEST (Geneva) / 10:00 – 11:00 EDT (New York) Topic: Join us on July 27th to commemorate World Head and Neck Cancer Day with an important and free webinar. We will delve into critical aspects […]
IPVS Regional Webinar 2021: Cervical Cancer Elimination in Asia Pacific
Register today for the IPVS regional webinar in collaboration with the APAC HPV Coalition: Session III: Cervical cancer vaccination & screening in the Asia pacific during the pandemic: Where do we go from here? 15 May 2021 08:00-9:00 CET (Geneva)/ 14:00-15:00 SST (Singapore) Topic: What are the main challenges in cervical cancer screening and prevention […]
IPVS webinar: What does it take to decide if a cancer is caused by HPV?
IPVS webinar What does it take to decide if a cancer is caused by HPV? Wednesday, 21st September 2022 16:00-17:30 CEST (Geneva) / 10:00-11:30 EDT (New York) Topic: This live and free webinar will be about determining causal relations for cancers associated with HPV. In this session, the speakers will: • explain the scientific criteria […]
IPVS/IANS webinar – Anal HPV and host interactions
Joint IANS/IPVS webinar: Anal HPV and host interactions Wednesday, 6 September 2023 16:00 – 17:00 CEST (Geneva) / 10:00 – 11:00 EDT (New York) Join us for a free webinar on anal HPV and host interactions in Anal Intraepithelial Neoplasia (AIN) and Cancer. In this live session, we will delve into cutting-edge research and knowledge […]
IPVS webinar – Your patient is HPV+: what is next?
IPVS webinar – Your patient is HPV+: what is next? Tuesday, 13th July 2021 8:00 EDT (New York) / 14:00 CEST (Geneva) / 20:00 SST (Singapore) Topic: Given the strong evidence that HPV-based screening is more effective than cytology or naked visual inspection after application of acetic acid, more and more countries have switched or […]
IPVS webinar: Cultural Insights about HPV vaccination in the MENA region
IPVS educational webinar: Cultural Insights about HPV vaccination in the MENA region* *Middle East and North Africa (MENA) region Tuesday, 25th October 2022 13:30-14:30 CEST (Geneva) / 7:30-8:30 EDT (New York) / 15:30-16:30 GST (Muscat) Topic: This webinar will discuss cultural normative values toward sexuality and the implications for HPV education and vaccination programs. It […]
Regional webinar: Lessons learnt from the Covid19 pandemic- Innovations for cervical cancer elimination in the Asia Pacific
IPVS regional webinar in collaboration with the Asia Pacific HPV Coalition: Lessons learnt from the Covid19 pandemic- Innovations for cervical cancer elimination in the Asia Pacific Thursday, 29 August 2024 08:00-09:15 CEST (Geneva)/ 14:00-15:15 SGT (Singapore) Topic: The COVID-19 pandemic demonstrated global unity in fighting a common threat, leading to new technologies that improved access […]
IPVS webinar – HPV latency: more questions than answers
IPVS webinar – HPV latency: more questions than answers Wednesday, 29th September 2021 10:00 EDT (New York) / 16:00 CEST (Geneva) Topic: The ability of papillomaviruses to establish infection at human epithelial sites that is largely undetectable by most routine molecular diagnostic tests is indisputable. However, there remains considerable disagreement about what this ‘test negative, […]
